Ribavirin Arm published presentations and documents on DocSlides.
versus. . Interferon alfa-2b + Ribavirin . Phase...
Phase 3. Treatment. . Naïve, Chronic HCV. McHut...
NIH SPARE. Phase . 2. Treatment. . Naïve . (unf...
-. 0938 in GT 1-4. QUANTUM. Phase . 2b. Treatment...
Sofosbuvir + Ribavirin to Prevent Post-Transplan...
versus. Interferon alfa-2b + Ribavirin. Phase 3. T...
Following Liver Transplantation. Phase 2. Charlton...
+ Ribavirin to Prevent Post-Transplant HCV Recur...
RESPOND-2. Phase . 3. Treatment. . Experienced. ...
TURQUOISE-II. Phase 3. . Treatment. Naïve and ...
SAPPHIRE-I. Phase 3. . Treatment. . Naïve. Fel...
Treatment –Experienced Genotype . 1 . ASPIRE Tr...
versus . Telaprevir. . with PR in GT1 . ATTAIN ...
. +/- Ribavirin in HCV Genotype 1, 4 or 6. C-EDG...
Pegasys. ). Prepared by: David Spach, MD & H....
with PEG + RBV in Genotype 1. SPRINT. -1. Phase ....
SPRINT-2. Phase 3, Treatment . Naive. Treatment. ...
VALENCE Trial. Phase . 3. Treatment. Naïve and ...
Flat versus Weight-Based Ribavirin Dosing. Phase ...
. alfa. -. 2b. . + RBV vs. . Peginterferon alfa...
Ribavirin in PI-experienced HCV GT1. C-SALVAGE...
Geoghegan. . Information . Treatment for hepatit...
Update. David Spach, MD. Professor of Medicine,...
SPRINT. -1. Phase . 2. Treatment. . Naïve. Kwo. ...
for Patients with Prior Failure to PEG + RIB. PRO...
PTV150/r + OBV + . DSV . + RBV. PTV150/r + . DSV...
Number People with Reactive anti-HCV Antibody. Un...
Number People with Reactive anti-HCV Antibody. Un...
OBV/PTV/r + . DSV . + RBV. OBV/PTV/r + . DSV . + ...
Number People with Reactive anti-HCV Antibody. Un...
Number People with Reactive anti-HCV Antibody. Un...
Hepatitis-2015. Orlando. , USA. July 20 - 22 20...
Number People with Reactive anti-HCV Antibody. Un...
Number People with Reactive anti-HCV Antibody. Un...
Number People with Reactive anti-HCV Antibody. Un...
Number People with Reactive anti-HCV Antibody. Un...
Number People with Reactive anti-HCV Antibody. Un...
Paritaprevir. -. Ritonavir (. Technivie. ). Prepa...
Number People with Reactive anti-HCV Antibody. Un...
AASLD. 2014: Abstract 1939. 3D = Ombitasvir-Pari...
Copyright © 2024 DocSlides. All Rights Reserved